Already FDA-approved to treat major depression and migraines, TMS can now be marketed as a treatment for obsessive compulsive disorder Santa Barbara, Calif., September 21, 2018 – Transcranial Magnetic Stimulation (TMS) therapy is rapidly growing in popularity as a treatment [..]
At TheraMind Services, we are committed to improving the lives of patients by providing physicians with the most advanced therapeutic, non-drug alternatives, for treating a broad variety of neuropsychiatric disorders. Our doctors successfully treat patients suffering from treatment-resistant depression (TRD), Major Depressive Disorder (MDD), Anxiety Disorder, Perinatal and Postpartum Disorder (PPD), Post-Traumatic Stress Disorder (PTSD), Bipolar Disorder, Obsessive Compulsive Disorder (OCD) and other mood disorders. At many of our Centers we also routinely treat patients suffering from a variety of neurological disorders including Chronic Pain, Fibromyalgia, Migraines, Tinnitus, Stoke-related disorders, Concussion and TBI, and others.
We also employ advanced diagnostic technologies such as fMRI, genetic testing and Quantitative EEG (also known as brain-mapping) to assist our physicians and referring medical professionals in assessing patient needs. Our highly trained staff members are committed to providing outstanding supporting services to referring medical professionals, their patients and the patients’ family members.
The TheraMind Difference
At TheraMind, we believe that providing top mental and neurological health clinicians with the most advanced diagnostic and therapeutic technologies available leads to better patient outcomes. We see TMS and our other treatment modalities as tools—very effective ones—to be used by or in conjunction with patients’ existing medical doctors or mental health professionals to facilitate and enhance recovery from depression and other mood and neurological disorders when medications alone do not work.